Insider · CIK 0002040538
Meredith Emmerich
officer
Files at XYL (Xylem Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | XYL Xylem Inc. | AGrant or award Common Stock | +1,060 | $129.67 | $137k | 4,833 | Mar 6, 2025 |
| Mar 5, 2025 | XYL Xylem Inc. | AGrant or award Non-Qualified Stock Options (Right to buy)derivative | +3,721 | $129.67 | $483k | 3,721 | Mar 6, 2025 |
| Oct 21, 2024 | XYL Xylem Inc. | AGrant or award Common Stock | +3,772 | $132.54 | $500k | 3,772 | Oct 23, 2024 |
| Oct 21, 2024 | XYL Xylem Inc. | AGrant or award Stock Options (Right to buy)derivative | +33,138 | $132.54 | $4.4M | 33,138 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.